FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229366707> ?p ?o ?g. }

• W4229366707 endingPage "2520" @default.
• W4229366707 startingPage "2512" @default.
• W4229366707 abstract "Background: Elevated triglyceride and glucose levels are associated with an increased cardiovascular disease risk including ischemic stroke. It is not known whether the response to a combined oral triglyceride and glucose challenge after ischemic stroke improves identification of patients with increased risk for recurrent vascular events. Methods: The prospective, observational Berlin “Cream&Sugar” study was conducted at 3 different university hospital sites of the Charité–Universitätsmedizin Berlin, Germany, between January 24, 2009 and July 31, 2017. Patients with first-ever ischemic stroke were recruited 3 to 7 days after stroke. An oral triglyceride tolerance test (OTTT) and consecutive blood tests before (t 0 ) as well as 3 (t 1 ), 4 (t 2 ), and 5 hours (t 3 ) after OTTT were performed in fasting patients. An oral glucose tolerance test was performed in all nondiabetic patients 3 hours after the start of OTTT. Outcomes of the study were recurrent fatal or nonfatal stroke as well as a composite vascular end point including stroke, transient ischemic attack, myocardial infarction, coronary revascularization, and cardiovascular death assessed 1 year after stroke. Cox regression models were used to estimate hazard ratios and corresponding 95% CIs between patients with high versus low levels of triglyceride and glucose levels. Results: Overall 755 patients were included; 523 patients completed OTTT and 1-year follow-up. Patients were largely minor strokes patients with a median National Institutes of Health Stroke Scale score of 1 (0–3). Comparing highest versus lowest quartiles of triglyceride levels, neither fasting (adjusted hazard ratio t0 , 1.24 [95% CI, 0.45–3.42]) nor postprandial triglyceride levels (adjusted hazard ratio t3 , 0.44 [95% CI, 0.16–1.25]) were associated with recurrent stroke. With regard to recurrent vascular events, results were similar for fasting triglycerides (adjusted hazard ratio t0 , 1.09 [95% CI, 0.49–2.43]), however, higher postprandial triglyceride levels were significantly associated with a lower risk for recurrent vascular events (adjusted hazard ratio t3 , 0.42 [95% CI, 0.18–0.95]). No associations were observed between fasting and post–oral glucose tolerance test blood glucose levels and recurrent vascular risk. All findings were irrespective of the diabetic status of patients. Conclusions: In this cohort of patients with first-ever‚ minor ischemic stroke, fasting triglyceride or glucose levels were not associated with recurrent stroke at one year after stroke. However, higher postprandial triglyceride levels were associated with a lower risk of recurrent vascular events which requires further validation in future studies. Overall, our results do not support the routine use of a combined OTTT/oral glucose tolerance test to improve risk prediction for recurrent stroke." @default.
• W4229366707 created "2022-05-10" @default.
• W4229366707 creator A5001101402 @default.
• W4229366707 creator A5013882441 @default.
• W4229366707 creator A5027788177 @default.
• W4229366707 creator A5036649778 @default.
• W4229366707 creator A5043942088 @default.
• W4229366707 creator A5060503236 @default.
• W4229366707 creator A5067825430 @default.
• W4229366707 creator A5069274834 @default.
• W4229366707 creator A5075451343 @default.
• W4229366707 date "2022-08-01" @default.
• W4229366707 modified "2023-09-30" @default.
• W4229366707 title "Combined Oral Triglyceride and Glucose Tolerance Test After Acute Ischemic Stroke to Predict Recurrent Vascular Events: The Berlin “Cream&Sugar” Study" @default.
• W4229366707 cites W1973860866 @default.
• W4229366707 cites W1977335231 @default.
• W4229366707 cites W1977868737 @default.
• W4229366707 cites W1986539635 @default.
• W4229366707 cites W1997256217 @default.
• W4229366707 cites W2020915011 @default.
• W4229366707 cites W2030076333 @default.
• W4229366707 cites W2079171633 @default.
• W4229366707 cites W2114989554 @default.
• W4229366707 cites W2149433053 @default.
• W4229366707 cites W2161219097 @default.
• W4229366707 cites W2169582126 @default.
• W4229366707 cites W2170875544 @default.
• W4229366707 cites W2342969428 @default.
• W4229366707 cites W2472767721 @default.
• W4229366707 cites W2625268475 @default.
• W4229366707 cites W2893835680 @default.
• W4229366707 cites W2900034165 @default.
• W4229366707 cites W2982561735 @default.
• W4229366707 cites W3158767720 @default.
• W4229366707 cites W3197326839 @default.
• W4229366707 cites W4235479662 @default.
• W4229366707 cites W4236832843 @default.
• W4229366707 cites W4292229870 @default.
• W4229366707 doi "https://doi.org/10.1161/strokeaha.122.038732" @default.
• W4229366707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35531780" @default.
• W4229366707 hasPublicationYear "2022" @default.
• W4229366707 type Work @default.
• W4229366707 citedByCount "0" @default.
• W4229366707 crossrefType "journal-article" @default.
• W4229366707 hasAuthorship W4229366707A5001101402 @default.
• W4229366707 hasAuthorship W4229366707A5013882441 @default.
• W4229366707 hasAuthorship W4229366707A5027788177 @default.
• W4229366707 hasAuthorship W4229366707A5036649778 @default.
• W4229366707 hasAuthorship W4229366707A5043942088 @default.
• W4229366707 hasAuthorship W4229366707A5060503236 @default.
• W4229366707 hasAuthorship W4229366707A5067825430 @default.
• W4229366707 hasAuthorship W4229366707A5069274834 @default.
• W4229366707 hasAuthorship W4229366707A5075451343 @default.
• W4229366707 hasBestOaLocation W42293667071 @default.
• W4229366707 hasConcept C126322002 @default.
• W4229366707 hasConcept C127413603 @default.
• W4229366707 hasConcept C134018914 @default.
• W4229366707 hasConcept C164705383 @default.
• W4229366707 hasConcept C188816634 @default.
• W4229366707 hasConcept C207103383 @default.
• W4229366707 hasConcept C2777466421 @default.
• W4229366707 hasConcept C2778163477 @default.
• W4229366707 hasConcept C2778913445 @default.
• W4229366707 hasConcept C2780645631 @default.
• W4229366707 hasConcept C44249647 @default.
• W4229366707 hasConcept C500558357 @default.
• W4229366707 hasConcept C50382708 @default.
• W4229366707 hasConcept C555293320 @default.
• W4229366707 hasConcept C68443243 @default.
• W4229366707 hasConcept C71924100 @default.
• W4229366707 hasConcept C78519656 @default.
• W4229366707 hasConceptScore W4229366707C126322002 @default.
• W4229366707 hasConceptScore W4229366707C127413603 @default.
• W4229366707 hasConceptScore W4229366707C134018914 @default.
• W4229366707 hasConceptScore W4229366707C164705383 @default.
• W4229366707 hasConceptScore W4229366707C188816634 @default.
• W4229366707 hasConceptScore W4229366707C207103383 @default.
• W4229366707 hasConceptScore W4229366707C2777466421 @default.
• W4229366707 hasConceptScore W4229366707C2778163477 @default.
• W4229366707 hasConceptScore W4229366707C2778913445 @default.
• W4229366707 hasConceptScore W4229366707C2780645631 @default.
• W4229366707 hasConceptScore W4229366707C44249647 @default.
• W4229366707 hasConceptScore W4229366707C500558357 @default.
• W4229366707 hasConceptScore W4229366707C50382708 @default.
• W4229366707 hasConceptScore W4229366707C555293320 @default.
• W4229366707 hasConceptScore W4229366707C68443243 @default.
• W4229366707 hasConceptScore W4229366707C71924100 @default.
• W4229366707 hasConceptScore W4229366707C78519656 @default.
• W4229366707 hasIssue "8" @default.
• W4229366707 hasLocation W42293667071 @default.
• W4229366707 hasLocation W42293667072 @default.
• W4229366707 hasOpenAccess W4229366707 @default.
• W4229366707 hasPrimaryLocation W42293667071 @default.
• W4229366707 hasRelatedWork W1238589527 @default.
• W4229366707 hasRelatedWork W2148404892 @default.
• W4229366707 hasRelatedWork W2917591686 @default.
• W4229366707 hasRelatedWork W3047572963 @default.
• W4229366707 hasRelatedWork W3108721673 @default.

• next